Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Goals of the International Cancer Microbiome Consortium

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.09.17
Views: 972

Mr James Kinross - Imperial College London, London, UK

Mr James Kinross talks to ecancer at the Microbiome in Cancer and Beyond 2017 meeting about the International Cancer Microbiome Consortium and it's goals. 

The ICMC was set up to discuss the role of the microbiome in cancer intiation, progression, and therapeutics. This is essential due to the rapid evolution of this field, and to continuously share research, standardise terms and share techniques. It also allows the identification of gaps in research and streamlining this research towards clinical practice.

The ICMC is set to continue as the data grows, and Mr Kinross hopes it will educate both clinicians, funding bodies, and patients alike. 

Related videos

follow us

War on Cancer 2018

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation